Oncogene Cancer Research
@OncogeneCancer
Patients & families funding & advocating for #research into oncogene-driven cancers, like EGFR, ALK & others that originate in the lungs. #ResearchMatters #LCSM
ID:1663121732159275011
http://www.oncogeneresearch.org 29-05-2023 09:55:28
1,6K Tweets
635 Followers
931 Following
Follow People
BLKHLTH
We’re creating a space for conversations about racism, health, and new ways forward. Partner with us ✉️: [email protected]
Angela Churie Kallhauge
Executive Vice President - Impact @EnvDefenseFund. 🇰🇪🇸🇪 Climate change optimist and believer in people-centered 🌍 solutions. 🫁🏌️♀️🎶 All views my own.
Dárcia Lima
Do Brasil para o mundo, enfermeira, política,amante de F1
NCCS - National Coalition for Cancer Survivorship
Founded in 1986, the National Coalition for Cancer Survivorship advocates for quality cancer care for all people touched by cancer.
Allison Rosen, MS
#Cancer survivor, patient #advocate, Public #speaker, @AmericanCancer Director Project ECHO, @MDAndersonNews @SWOG volunteer. #crcsm #ayacsm Views my own
It's personal because we live it, we experience loss from it, we fear it, we question it, we hate it...but most of all - we JUST want to LIVE despite it! #younglungcancer @florez_Lab@ EGFR Resisters @alkpositiveinc Narjust Florez, MD, FASCO Oncogene Cancer Research RETpositive
New #clinicaltrial will examine a novel oncolytic virus called MEM-288 in combination w the immunotherapy agent, Opdivo (nivolumab), in #lungcancer Moffitt Cancer Center. Aim to determine ORR of MEM-288 + Opdivo
Those w EGFR or ALK must have been treated w a TKI.
curetoday.com/view/oncolytic…
Stephen V Liu, MD Marina Garassino Real world compliance with full dose adjuvant therapies is much lower than in trials
🇬🇧 adjuvant Osimertinib RWE study found dose reduction rate double that of ADAURA
Suspect we might see similar with adjuvant Alectinib?
Insightful discussion from top thoracic oncologists on #EGFR + #LungCancer treatments. Trials like FLAURA2 & MARIPOSA reveal promising options, but also highlight how complex treatment decisions can be in the face of data gaps. Eric K. Singhi, MD Sandip Patel MD Maya K. Khalil, MD
Thank you Oncogene Cancer Research for inviting me to talk about one of The Christie NHS #ePROMs work presented at BTOG
✅Fill the gap in patient monitoring during/after RT using ePROMs
✅Adapt our care to the patient needs
❌One-size-fits-all follow-up model
Next, present similar…
How can we improve the patient experience around #radiotherapy ?
Dr Thitikorn Nuamek (Thitikorn Nuamek (Pao)), Clinical Research Fellow The Christie Charity, shared research @BTOG using online patient questionnaires which highlighted gaps to do just this. Have a listen to his recap.
#LCSM
Yvonne Diaz Charles Swanton Born to Game The Crick It was a cracking talk and for BTOG members it’s free to stream via the website
We've been talking the talk, but Narjust Florez, MD, FASCO is walking the walk 👏🏼
The FIRST EVER International Pregnancy and Lung Cancer Registry created by #FlorezLab
Please bookmark & share!
#LCSM
Big news for European #cancer #patients 🇪🇺
Selpercatinib has been approved by EU Medicines Agency for advanced RET fusion positive solid tumours 🎯
This marks the 2nd tumour agnostic, biomarker-driven approval in the EU.
#PrecisionMedicine OncoAlert 🚨
ec.europa.eu/health/documen…
#FlorezLab Young Lung Cancer Initiative 6b/
🫁💡Superior #OverallSurvival was observed in females, patients with TKI-sensitive EGFR mutations or ALK rearrangements, earlier stage and patients with adenocarcinoma subtype.
🫁💡Rapid genomic profiling is crucial in #younglungcancer ‼️
🔗:ncbi.nlm.nih.gov/pmc/articles/P…
Lung cancer is on the rise in younger people but we don’t understand why. Some startling facts in Tweetorial below from Dr Narjust Florez, MD, FASCO & Young Lung Cancer Initiative.
Worth bookmarking and making sure your loved ones know you only need lungs to get lung cancer. Thanks Cancer! 👇
#LCSM